Next Article in Journal
Inflammatory Load Across Diabetes Duration: CRP and ESR Patterns and Their Metabolic Correlates
Next Article in Special Issue
Finishing Barrow Skeletal Muscle Performance and Fatigue Response to Large-Dose Nicotinamide Riboside Supplementation
Previous Article in Journal
Metabolomic Profiling of Tyrosine Kinase Inhibitor-Induced Endothelial Dysfunction and Cardiovascular Toxicity
Previous Article in Special Issue
Repeated Cold Water Stress Leads to Improvements in Mitochondrial Metabolism of Skeletal Muscles in Rats
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Metabolites
Volume 16
Issue 3
10.3390/metabo16030201
metabolites-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dietary Citrus Peel Supplementation Enhances Hepatic Energy Metabolism, Muscle 9-HODE Generation and Isoleucine Catabolism in Beef Cattle

by
Susumu Muroya
1,2,*,
Koichi Ojima
2,
Arata Banno
3,
Hirotaka Nagai
3,
Kazumasa Kakibuchi
4,
Takuma Higuchi
5,
Shuji Sakamoto
5 and
Kazutsugu Matsukawa
3,*
1
Department of Animal Science and Welfare, Kagoshima University, Korimoto 890-0065, Kagoshima, Japan
2
Division of Animal Products Research, NARO Institute of Livestock and Grassland Science (NILGS), Tsukuba 305-0901, Ibaraki, Japan
3
Department of Agriculture and Marine Science, Kochi University, Nankoku 783-8502, Kochi, Japan
4
Shikoku Research Institute Inc., Nishimachi, Takamatsu 761-0192, Kagawa, Japan
5
Science Research Center, Kochi University, Nankoku 783-8505, Kochi, Japan
*
Authors to whom correspondence should be addressed.
Metabolites 2026, 16(3), 201; https://doi.org/10.3390/metabo16030201
Submission received: 10 February 2026 / Revised: 7 March 2026 / Accepted: 14 March 2026 / Published: 18 March 2026
(This article belongs to the Special Issue Muscle Metabolic Response and Adaptation to Exercise, Diet, and Environment: 2nd Edition)
Browse Figures
Versions Notes

Abstract

Background: Citrus components potentially suppress adipogenic differentiation and lipid accumulation, and exhibit anti-inflammatory and antioxidant effects. We hypothesized that the bioactive compounds in Citrus junos Sieb ex Tanaka (yuzu) fruit peel can alter the systemic metabolism and productivity of beef cattle. Methods: Japanese Brown (JBR) steers were fed with a diet supplemented with 2.5% yuzu peel during the last month of the finishing period. To investigate the effect of dietary yuzu supplementation (DYS) on beef and liver metabolism, we explored the metabolomic profiles of longissimus thoracis (LT, loin) muscle at 14 d postmortem using capillary electrophoresis (CE-TOF/MS) and high-performance liquid chromatography time-of-flight mass spectrometry (LC-TOF/MS). Results: The DYS treatment enhanced the beef fat score compared to that recorded in beef in the no-DYS (None) group (p = 0.050); however, the other carcass quality traits were not significantly different between the DYS and None groups. CE-TOF/MS and LC-TOF/MS revealed 242 and 107 annotated peaks, respectively, for the LT muscle. DYS significantly increased 9(S)-hydroxyoctadecadienoic acid (9-HODE, a beef flavor precursor), cyclo(-Leu-Pro), spermidine, asymmetric dimethylarginine, and 7α-hydroxycholesterol levels and reduced 2-ethylhydracrylic acid (2-EHAA), γ-tocopherol, coenzyme Q10 (CoQ10), sphingomyelin(d18:1/16:0), Cys-Gly, Tyr-Arg, and palmitoylcarnitine levels in postmortem LT muscle (p < 0.050). Concomitantly, in the fresh liver, DYS increased acetyl-CoA, 6-phosphogluconic acid, S-methylglutathione, ATP, ribulose 5-phosphate, and ADP levels and suppressed the content of thiamine, Ala-Ala, riboflavin, and ascorbate 2-sulfate (p < 0.050). Conclusion: Collectively, yuzu ingredients activated ATP production in the liver through the elevation of hepatic energy metabolism primarily in the citrate cycle and β-oxidation, and potentially altered muscle metabolism, including linoleic acid oxidation, FAD-mediated electron transport chain, and isoleucine catabolism, as demonstrated in the reduced accumulation of 2-EHAA and CoQ10 in DYS beef. Moreover, DYS likely affects the gut microbiome by enhancing the production of cyclo(-Leu-Pro), an antimicrobial dipeptide.

Graphical Abstract

1. Introduction

Citrus fruits have multiple beneficial effects on human health when consumed as a plant-based food. Their dietary effects have been documented in studies investigating the health benefits of the Mediterranean diet [1,2,3], with several studies demonstrating reduced risks of cardiovascular disease (CVD) [4,5,6], diabetes [7,8], and cancers [9]. Various types of citrus fruits are enriched in bioactive compounds [5,10,11], such as carotenoids, terpenes, limonoids, and flavonoids. Accumulating evidence suggests that citrus flavonoids, including flavones, flavanones, flavonols, isoflavones, anthocyanidins, and flavanols [12,13], exert antioxidant [13], hypolipidemic [14], hypoglycemic [15,16], and anticarcinogenic bioactivities [17,18]. Dietary citrus flavonoids evoke their functions to modulate systemic glucose and lipid metabolism, exerting hyperlipidemic and hyperglycemic effects in humans and animals [19,20].
The positive effects on human health are not limited to the edible citrus fruits but have also been detected in citrus processing waste [21,22]. Citrus peels contain major beneficial flavonoid compounds, including naringin, hesperidin, and nobiletin, which exhibit bioactivities comparable to those of fruits [23,24]. Animal model experiments have demonstrated the hypoglycemic, hypocholesterolemic, and antioxidant effects of naringin [25,26,27,28,29], thereby reducing obesity risks [30,31]. Hesperidin also exhibits hyperlipidemic, hyperglycemic, and antioxidant activities [32,33,34,35]. Most of these activities, as well as the stimulating effect of adipose thermogenesis, are shared by naringin and hesperidin [31,36]. Furthermore, nobiletin has been reported to alter liver metabolism [37], leading to the amelioration of hepatic steatosis [38] and enhancement of skeletal muscle mass [39]. These studies further suggest a broad-range impact of nobiletin on the modulation of gut microbiota and homeostatic metabolism [37,40].
In animal science and industries, citrus waste has been highlighted as a dietary supplement owing to its potential benefits in improving animal growth performance and meat quality. The beneficial effects of citrus pulp are likely associated with various ingredients, such as naringin and hesperidin, which alter the expression of genes involved in antioxidant activity [41] and lipid metabolism [42,43]. High proportions (24–35%) of dried citrus pulp in a concentrate-based diet altered the fatty acid composition in lamb [44] and ostrich muscles [45] and improved meat oxidative stability in lambs [46]. In addition, citrus pulp-supplemented diets improve beef quality, sensory attributes [47,48] and oxidative stability [49,50,51]. However, the effect of citrus waste administration on metabolic alteration in beef cattle remains inadequately characterized. Previous reports inspired us to hypothesize that dietary citrus peel supplementation alters hepatic lipid and skeletal muscle metabolism in beef cattle.
Therefore, we investigated citrus peel-supplemented diet-induced variation in hepatic and skeletal muscle metabolism in Japanese Brown (JBR) cattle, a minor population breed with moderately marbled beef and high growth performance [52,53,54]. In this study, we used the peel of Citrus junos Sieb ex Tanaka (yuzu) as a citrus-based supplement with known antioxidant activity [55,56]. The postmortem aged beef and fresh livers of cattle fed the yuzu peel-supplemented diet were analyzed using capillary electrophoresis (CE-TOF/MS) and/or high-performance liquid chromatography time-of-flight mass spectrometry (LC-TOF/MS) to obtain comprehensive metabolite profiles.

2. Materials and Methods

2.1. Animals

Six JBR steers (Kochi [Tosa] pedigree [JBRT]) were fed and reared at Kochi University farm until 28 months of age. The basic individual diets were designed based on energy and nutrient requirements according to the standard diet model of the Japanese Feeding Standard for Beef Cattle (JFSBC, 2008 ed.) [57] following a previously described method [52]. The cattle were assigned to two dietary treatment groups (n = 3 for each): treated with (DYS) or without (None) yuzu supplementation. Supplementation was provided as 2.5% (w/w) of yuzu peel during the last month of the finishing period. Beef quality was evaluated using dressed carcasses at a commercial slaughterhouse (Meat Pro Kochi, Kochi, Japan), according to a standard determined by the Japan Meat Grading Association (https://www.jmga.or.jp/; 9 September 2023).

2.2. Muscle and Liver Samples

Fresh liver samples were collected immediately after the slaughter. The longissimus muscle (LT) was stored for 14 days at 2 °C after slaughter. From the postmortem-aged muscle, lean portions of small LT muscle pieces were carefully collected from multiple locations in the muscle. Liver and muscle samples were stored at −80 °C until use.

2.3. CE-TOF/MS Measurement

Samples for CE-TOF/MS measurements were prepared as previously described [52,58]. For this analysis, frozen muscle pieces (approximately 27.7–38.5 mg) were rapidly immersed in 50% acetonitrile containing 10 μM Internal Standard Solution 1 (Human Metabolome Technologies (HMT), Tsuruoka, Japan) and homogenized at 0 °C, followed by centrifugation at 2300× g for 5 min at 4 °C. Subsequently, the aqueous phase was filtered using a 5 kDa cutoff membrane. The lyophilized filtrate was suspended in Milli-Q water and analyzed using an Agilent CE capillary electrophoresis system (Agilent Technologies, Waldbronn, Germany), while maintaining the analytical conditions consistent with those used in a previous study [58].

2.4. LC-TOF/MS Measurement

For LC-TOF/MS analysis, the frozen muscle pieces (25.2–45.4 mg) were immediately soaked in 1% formic acid/acetonitrile solution containing internal standards (H3304-1002, HMT). Subsequently, the samples were crushed three times under frozen conditions for 120 sec at 1500 rpm, followed by one crushing cycle after the addition of 1% formic acid solution and a final cycle after the addition of Milli-Q water. Following a centrifugation step (2300× g, 5 min, 4 °C), the upper layer solution was filtered using a 3 kDa cutoff filter (NANOCEP 3k OMEGA, PALL Corporation, Ann Arbor, MI, USA) to remove macromolecules and subsequently filtered through a Hybrid SPE-Phospholipid cartridge (Hybrid SPE-Phospholipid 30 mg/mL, SUPELCO, Bellefonte, PA, USA). The lyophilized filtrate was suspended in 50% isopropanol aqueous solution and analyzed by LC-FT/MS. Metabolomic analyses were performed using an Agilent 1260 series RRLC system SL (Agilent Technologies, Waldbronn, Germany) combined with an Agilent LC/MSD TOF MS system (Agilent Technologies, Waldbronn, Germany). The conditions (e.g., flow rate and gradient conditions) for metabolite separation using an octadecylsilyl (ODS) column were set following a previous report for cation and anion modes [53]. ESI-MS was conducted in the positive and negative ion modes, with capillary voltages of 4000 and 3500 V for cationic and anionic mode analyses, respectively. The spectrometer scanned from 100 to 1700 m/z.

2.5. Data Analysis of MS Measurement Results

Raw CE-TOF/MS and LC-TOF/MS data were analyzed using MasterHands software (ver. 2.19.0.2) using a previously described method [53]. For this analysis, the signal peaks of isotopomers, adduct ions, and other product ions of known metabolites were removed, all signal peaks of interest were extracted, and their migration times (MTs) or retention times (RTs) were normalized to those of the internal standards. Alignment of the peaks was performed, and the detected peaks were annotated using the HMT metabolite database. To analyze the relative compound levels between the feeding treatments, the peak areas were further normalized using the sample weight. In the comparative analysis, the abundance of undetected compounds was considered zero.

2.6. Statistical Analyses

The differences in daily gain (DG), final body weight (BW), carcass weight, rib eye area (REA), and subcutaneous fat thickness (SFT) between the dietary treatments were tested using the Welch’s t-test, whereas variations in beef marbling, color, and fat scores were assessed using the Mann–Whitney U-test. Relative content values were analyzed using MetaboAnalyst (https://www.metaboanalyst.ca/; 26 February 2024), based on principal component analysis (PCA), hierarchical cluster analysis (HCA), Student’s t-test, and metabolite set enrichment analysis (MSEA). The differences between treatments with and without DYS were considered statistically significant at p < 0.050, with a difference trend at 0.050 ≤ p < 0.100. In the OPLS-DA score plot, the confidence level of the ellipse was 95%.

3. Results

3.1. Result of Carcass Evaluation

The effects of the DYS treatment on beef cattle carcasses are presented in Table 1. Most of the quality traits of carcasses were not affected by DYS; however, the beef fat score, primarily determined by fat color and gloss, was higher in beef supplemented with yuzu than in the None group (p = 0.050).

3.2. Effect of DYS on the JBR Beef Metabolome

To understand the effects of DYS on the JBR beef quality and postmortem metabolism, we profiled beef metabolites. In total, 242 and 107 annotated peaks were detected using CE-TOF-MS and LC-TOF-MS, respectively, across all beef samples examined (Supplementary Tables S1 and S2).
The CE-TOF/MS and LC-TOF/MS beef metabolome profiles were then integrated, and the data were analyzed using multivariate methods with HCA and PCA. The HCA of aged LT muscle samples revealed variations in highly different 50 metabolites between the DYS and None groups (Figure 1), which were attributed to the characteristic distribution of representative beef metabolites and their abundance in beef samples. In both the HCA heatmap and volcano plot, suppression of 2-ethylhydracrylic acid (2-EHAA), γ-tocopherol, Coenzyme Q10 (CoQ10), and sphingomyelin (d18:1/16:0) and an increase in 9(S)-hydroxyoctadecadienoic acid (9(S)-HODE) in DYS beef highly contributed to the beef sample separation between DYS treatments (Table 2). On the other hand, the beef samples were not distinguished between the two groups based on the metabolomics profile in PCA (Supplementary Figure S1). In addition, the levels of dipeptide cyclo(-Leu-Pro) (cLP), spermidine, asymmetric dimethylarginine (ADMA), and 7α-hydroxycholesterol (7α-OHCh) were higher in the DYS group than in the control group, whereas Cys-Gly, Tyr-Arg, and palmitoylcarnitine (PALCAR) were reduced (p < 0.050, Table 2). Acylcarnitine(14:0) (p = 0.080) and acylcarnitine(18:1) (p = 0.092) were less abundant in the DYS group than in the control group.
MSEA was performed to understand the metabolic mechanisms underlying the effects of DYS on beef. For beef analysis, we used data from a set of 310 metabolites, which included the most abundant single isomer of each lipid metabolite, with unidentified steric isomers. As shown in Figure 2, among the top 25 differentially abundant metabolites between the two dietary treatments, only Taurine and Hypotaurine Metabolism exhibited a trend of difference in the DYS group (p = 0.088). Therefore, although aged LT muscle metabolism was not likely to be modulated, several lipids and metabolites linked to oxidative phosphorylation (OXPHOS), such as CoQ10 and 9(S)-HODE, were affected by DYS (Figure 1).

3.3. Effect of DYS on the JBR Liver Metabolome

Since DYS affects specific lipids and the oxidation-associated metabolite CoQ10, we hypothesized that DYS affects energy metabolism in the liver, the major tissue involved in CoQ10 biosynthesis [59], which potentially modulates skeletal muscle metabolism. Accordingly, we analyzed the metabolomic profiles of fresh livers collected from steers in the DYS and None groups using CE-TOF/MS to focus on energy metabolism-associated metabolites. In this analysis, 308 annotated peaks were detected across all tested liver samples (Supplementary Table S3).
The HCA results for highly different 50 metabolites revealed clear discrimination of the liver samples based on dietary treatments (DYS and None) (Figure 3). Acetyl-CoA, 6-phosphogluconate (6-PG), S-methylglutathione (MGSH), and ATP levels were higher, and thiamine levels were reduced in the DYS liver more than in its None counterpart (Figure 3, Table 3). Although the liver samples were not distinguished between the DYS and None groups by the metabolomics profile in PCA (Supplementary Figure S2), higher levels of ribulose 5-phosphate (Ru5P) and Ala-Ala and lower levels of ADP, riboflavin, and ascorbate 2-sulfate (ascorbate 2-S) in the DYS group compared with those in the control group (p < 0.050) were also observed (Table 3) in addition to the five representative metabolites. Furthermore, glutamic acid (Glu, p = 0.059), glucose 1/6-phosphate (G1P/G6P, p < 0.100), and citric acid (p = 0.091) showed a trend of higher levels in the DYS group than in the None group, while succinic acid was at a lower level (p = 0.047) (Table 3).
Furthermore, we performed MSEA focusing on the liver metabolome profile, comprising 287 metabolites. The top 25 liver metabolic processes depicted in Figure 4 differed significantly between the two dietary treatments (p < 0.050). These representative metabolisms were mainly associated with fatty acid oxidation in mitochondria (e.g., β-oxidation, acetyl group transfer, electron transport chain) and energy substrate metabolisms (e.g., metabolisms of propanoate, pyruvate, citrate). The DYS steer liver samples also exhibited alterations in the steroid synthesis and metabolism of tryptophan, folate, butyrate, aspartate, sulfur compounds, thiamine, and riboflavin. These results indicate that DYS significantly affected fatty acid oxidation, the tricarboxylic acid (TCA) cycle, and mitochondrial OXPHOS in the liver of JBR steers.

4. Discussion

The present study revealed the DYS-induced alteration in the metabolome profile in aged beef, which was particularly associated with lipid metabolism and OXPHOS, such as γ-tocopherol, CoQ10, and 9-HODE. The results suggest that DYS led to lipolysis but suppressed lipogenesis, as demonstrated by previous in vivo and in vitro studies on citrus fruits and peels [60,61,62]. The anti-lipogenic effects are potentially driven by the major functional flavonoids, such as naringin and hesperidin, derived from citrus tissues via oxidative [29,63], thermogenic metabolic pathways [64], or β-adrenergic receptor signaling [65,66,67].

4.1. Lipid Oxidation

As shown in Figure 1B, 9-HODE levels in JBR beef were significantly higher in the DYS group than in the None group. Intriguingly, 9-HODE was recently reported to be the primary precursor of γ-hexalactone [68]. Lactones, including γ-hexalactone, are generated as key volatile compounds associated with the “sweet beef aroma” from linoleic acid in thermal-cooked beef from Japanese Black (Wagyu) cattle [69,70], a world-renowned breed characterized by high intramuscular fat (marbling) content and sweety aroma. Although JBR beef, including that examined in this study, exhibits a lower level of marbling than that observed in the Wagyu beef, the JBR beef fed DYS might have a stronger sweet aroma than beef fed without DYS supplementation.
The original 9-HODE content in citrus and its generation from other lipids after dietary intake in beef remain inadequately understood. The synthesis of 9-HODE is enhanced by the oxidation of fatty acids, primarily linoleic acid [71,72], in oxidized low-density lipoproteins (LDL) [73]. Moreover, triglyceride-rich lipoprotein lipolysis increases the 9-HODE level [74]. In this study, the decline in Cys-Gly, the degradation product of glutathione, and a trend of elevated oxidized glutathione (GSSG) content (p < 0.100; Table 2) potentially reflect that DYS modulates the oxidative microenvironment in aged beef tissues. Accordingly, linoleic acid in the muscle tissue is potentially more prone to oxidation, leading to 9-HODE formation, in DYS steers than in non-DYS steers. Therefore, yuzu peel ingredients likely contributed to the enhancement of linoleic acid oxidation; however, further investigation can clarify the mechanism underlying this oxidation.
In terms of lipid oxidation, an increase in 7α-OHCh was in line with that in 9-HODE (Table 2). 7α-OHCh, a primary oxidation product in the 7α-hydroxylation of cholesterol, is both enzymatically and non-enzymatically (by free radical oxidation) formed. The enzymatic reaction is catalyzed by cholesterol 7α-hydroxylase (CYP7A1) [75], which is a rate-limiting step of bile acid synthesis under most conditions [76]. Since both linoleic acid and cholesterol are loaded onto LDL and transported from the liver to recipient tissues through circulation, we consider that both compounds might be derived from the liver and transported by LDL; the abundance of linoleic acid in human LDL corroborated this fact [77]. Collectively, the increase in linoleic acid and cholesterol oxidation products supports the hypothesis that DYS upregulated lipid oxidation in the DYS group. Furthermore, these changes in muscle fatty acid metabolism potentially contributed to the improvement in beef fat score, especially promoting the color and gloss, by altering lipid composition.
The increase in ADMA levels in aged beef also suggests that DYS induces lipid oxidation in the LT muscle (Table 2). ADMA, an endogenous inhibitor of nitric oxide (NO) synthase, is generated by arginine N-methyltransferase (PRMT). Oxidized LDL, enriched in oxidized lipids, induces PRMT expression in endothelial cells [78,79]. Overall, the increase in ADMA in DYS beef was likely triggered by lipid oxidation in the muscle.
Macrophages in muscle or intramuscular fat tissue may also be considerably involved in 9-HODE generation because 9-HODE is generated from linoleic acid by arachidonic acid 15-lipoxygenase (ALOX15) in macrophages at the onset of the proinflammatory process [80]. The increasing trend in histamine levels observed in this study (Table 2; p = 0.051) was in line with the context of pro-inflammation. 9-HODE is a ligand of endogenous peroxisome-proliferator-activated receptor γ (PPARγ) and regulates macrophage gene expression through PPARγ [73]. Moreover, 9-HODE generated in the tissue macrophages induced the differentiation of preadipocytes into brown/beige adipocytes [80], indicating its role in the non-inflammatory removal of apoptotic white adipocytes during adipose remodeling. Interestingly, orange juice [81], which contains hesperidin [82], potentially exhibits anti-inflammatory effects. These results suggest that yuzu ingredients elicit lipid oxidation, leading to 9-HODE generation in tissue macrophages in bovine muscle. This might accompany feedback activation of macrophages through PPARγ, which might result in alteration of adipose deposition in skeletal muscle tissue of DYS steers.
Furthermore, the potential yuzu ingredients nobiletin, naringin, and hesperidin might directly regulate expression of PPARG, peroxisome-proliferator-activated receptor α (PPARA), and PPARG coactivator 1 α (PGC1A) in the marbling fat depot in DYS beef tissue. Particularly, naringin has a crucial impact on adipogenesis and fatty acid oxidation through downregulation of PPARG and upregulation of PPARA and PGC1A [64]. Since expression or activity of these genes remain unknown due to a lack of fresh muscle samples in this study, further studies are required to elucidate mechanisms on how dietary yuzu ingredients alter metabolism through transcriptional regulation.

4.2. FAD-Mediated Muscle Redox Metabolism and Isoleucine Catabolism

Intriguingly, the levels of CoQ10, PALCAR, and 2-EHAA decreased in DYS-aged beef (Table 2). 2-EHAA is normally present in urea at low levels as a catabolic end-product; however, it accumulates when isoleucine catabolism is impaired [83]. Given the reduced 2-EHAA levels (Figure 1B, Table 2), it is likely that isoleucine catabolism was enhanced in DYS beef through modulated activity of short/branched-chain-specific acyl-CoA dehydrogenase (SBCAD).
Deficiency of SBCAD activity is a well-known cause of the accumulation of 2-EHAA in urine and plasma [83]. Isoleucine is normally catabolized to (S) 2-methylbutyril CoA (2-MB CoA), generating acetyl-CoA and propionyl-CoA (Figure 5). During isoleucine catabolism, SBCAD dehydrogenates (S) 2-MB CoA to tiglyl-CoA, reducing flavin adenine dinucleotide (FAD) via a conjugation reaction [84]; thereby, it is involved in β-oxidation and amino acid catabolism. However, the inhibition of SBCAD activity, as illustrated in individuals with mutations in ACADSB, is associated with the accumulation of (S) 2-MB CoA and other intermediates, which affects racemic equilibration between isoleucine isomers and consequently leads to accumulation of 2-EHAA (Figure 5). In this study, as 2-EHAA levels decreased (Figure 1B, Table 2), DYS likely enhanced isoleucine catabolism rather than the allo-isoleucine pathway, which could be associated with upregulated SBCAD activity.
The modulated isoleucine catabolism was likely connected with alteration of CoQ10 and PALCAR by SBCAD, the key conjugating enzyme; however, it remains unclear how these β-oxidation-related metabolites were associated with the enhanced isoleucine catabolism. CoQ10, acting as an electron pool in electron transport chain (ETC), promotes phosphorylation of AMP-activated protein kinase (AMPK) and fatty acid oxidation (β-oxidation) [83,85,86]. In cases of aberrant SBCAD activity, FAD re-oxidation in the electron transfer flavoprotein (ETF)-catalyzed reaction can be modulated, potentially affecting the biosynthesis of CoQ10, because it is tightly connected to the redox reaction of FAD (Figure 5). Accordingly, CoQ10 and PALCAR levels might be affected by low availability of SBCAD activity due to the enhanced isoleucine catabolism, altered redox metabolisms, or modulated CoQ10 supply from liver. The redox reactions linked to the ETC may be associated with altered levels of GSSG and the degradation product Cys-Gly (p < 0.100; Table 2). Taken together, yuzu ingredients might have a different impact on isoleucine catabolism and β-oxidation in postmortem bovine muscle.
Given that β-oxidation and isoleucine catabolism were primarily confined to muscle cells, the phenotypic metabolite changes in DYS beef could be a result of altered gene expression of ACADSB in addition to AMPK genes. Based on the reduced muscle acylcarnitines and increased hepatic acetyl-CoA in DYS steers, the systemic energy was at a high level, suggesting that expression of ACADSB and/or the upstream genes might be upregulated.
cLP is generated by various bacteria and fungi, including gut microorganisms, but not by mammalian cells. Hence, it is occasionally found in food materials [87] and plays a role in the defense against other microorganisms and in growth suppression. Recently, cLP has been recognized as an anti-cariogenic and antifungal agent. Therefore, an increased level of cLP in DYS beef (Table 2) may improve the shelf life of beef; however, the mechanism underlying the DYS-induced increase in cLP content remains unclear. Microbiome analysis is necessary to investigate the potential contribution of changes in gut microbiota.

4.3. Liver Metaboilsm

DYS also altered hepatic metabolism, including the oxidation of branched-chain and very long-chain fatty acids, as demonstrated through MSEA (Figure 4). Particularly, in the liver, riboflavin levels decreased following DYS treatment. This might affect FAD metabolism and further modulate FAD redox-linked β-oxidation catalyzed by SBCAD and other Acyl-CoA dehydrogenases (ACDHs), consistent with our observation of significant metabolic alterations in mitochondrial β-oxidation, ETC, and acetyl group transfer (Figure 4). Cumulatively, β-oxidation in the liver was likely modulated by DYS. In contrast to β-oxidation, enhanced use of alternative energy substrates is suggested by the upregulated ATP and 6-PG generation (p < 0.050). Nevertheless, further investigation is required to elucidate the mechanisms underlying the alteration of energy metabolism in DYS steer livers. In the livers of DYS steers, acetyl-CoA (p = 0.002), G1P, G6P, and citric acid (p < 0.100) exhibited increasing trends, whereas succinic acid showed a reduced level (p = 0.047; Table 3), potentially indicating the downregulation of glycolysis and the TCA cycle, followed by accumulation of the glycolytic substrate G1P, which is possibly attributable to the accumulation of acetyl-CoA and citric acid. Alterations in energy metabolism are potentially linked to altered β-oxidation. Previous animal model-based research demonstrated that citrus ingredients, such as naringin, hesperidin, and nobiletin, exhibit multiple effects, particularly on energy metabolism, which include hypoglycemic and hypocholesterolemic improvement [25,26,27,28,29,37]. Accordingly, yuzu peel ingredients might modulate glycolysis and the TCA cycle in addition to β-oxidation in DYS steer liver. Further studies can clarify the underlying modulation of liver metabolisms. Naringin suppresses adipogenesis by downregulation of PPARG and enhances fatty acid oxidation by upregulation of PPARA, leading to the improvement of impaired lipid metabolism in a model of nonalcoholic fatty liver disease (NAFLD) [88]. Accordingly, yuzu ingredients including naringin might modulate the expression of adipogenesis regulatory genes in DYS liver.
Amino acid metabolites, such as tryptophan and aspartate, were also extracted in addition to valine, leucine, and isoleucine degradation (Figure 4). The analysis of aged DYS-treated beef samples reflected that isoleucine catabolism in the liver was affected by DYS in an FAD-associated manner. MGSH, a metabolite upregulated in the DYS-treated liver (p = 0.010), is generated by methylation of the SH group of glutathione, a major endogenous antioxidant [89]. Analysis using diabetic rats chronically administered C. unshiu extracts demonstrated that MGSH increased in the livers of mice fed dietary supplementation with Citrus tumida hort. ex Tanaka, suggesting that C. tumida reduces oxidative stress in hepatic tissues [90].

4.4. Limitations

In this study, three steers were assigned to each treatment, which constitutes a minimal number for the experimental design. Nonetheless, our findings reflecting the overall differences in metabolite profiles and metabolisms were in line with our previous reports on post-mortem aged beef. Hence, we conclude that the essential trend of metabolite distribution and differences observed in the current results appear consistent with the outcomes of the studies using larger numbers of animals; however, the results need to be confirmed through large-scale analyses in the future.

5. Conclusions

The present study demonstrated that DYS altered the metabolism of post-mortem aged beef and fresh livers. In beef, we detected alterations in 2-EHAA, PALCAR, and CoQ10 levels. Based on the metabolite network connecting these metabolites, the results suggest that DYS substantially modulated isoleucine catabolism and β-oxidation, which are associated with FAD redox and SBCAD activity. DYS also enhanced 9-HODE, a favorable flavor precursor in beef, indicating yuzu ingredient-mediated enhancement of linoleic acid oxidation. Moreover, DYS modulated hepatic metabolites in steers, particularly ATP and energy metabolism intermediates, which might be associated with changes in beef metabolites through circulation.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/metabo16030201/s1, Figure S1: PCA Score plot of beef samples, Figure S2: PCA Score plot of liver samples. Table S1: Detected features and information on the identification of the annotated peaks in CE-TOF/MS analysis of beef samples, Table S2: Detected features and information on the identification of the annotated peaks in LC-TOF/MS analysis of beef samples, Table S3: Detected features and information on the identification of the annotated peaks in LC-TOF/MS analysis of liver samples.

Author Contributions

Conceptualization, K.M.; methodology, S.M. and A.B.; validation, A.B. and K.O.; measurement, A.B.; data analyses, S.M. and K.O.; interpretation, S.M. and K.O.; resources, K.K., K.M. and H.N.; data curation, S.M., T.H. and S.S.; writing—original draft preparation, S.M.; writing—review and editing, S.M., A.B., T.H., S.S. and K.O.; funding acquisition, S.M. and K.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Japan Society for the Promotion of Science (JSPS KAKENHI 25K02159) to S.M. and the Livestock Promotional Subsidy of the Japan Racing Association (JRA) to K.M. (No. 21).

Institutional Review Board Statement

The animals were reared as outlined in the Guide for the Care and Use of Experimental Animals for the cattle (Animal Care Committee of Kochi University), and the committees approved the study (approval number P-00036; approval date 28 June 2022).

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article or Supplementary Materials (Tables S1–S3). The data presented in this study are available at doi.org/10.5281/zenodo.18592160.

Acknowledgments

We thank the farm staff at Kochi University for their great support in managing and feeding the cattle.

Conflicts of Interest

K.K. is an employee of Shikoku Research Institute Inc. The paper reflects the views of the scientists and not the company.

References

  1. Hertog, M.G.; Hollman, P.C.; Katan, M.B.; Kromhout, D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer 1993, 20, 21–29. [Google Scholar] [CrossRef] [PubMed]
  2. Hertog, M.G.; Kromhout, D.; Aravanis, C.; Blackburn, H.; Buzina, R.; Fidanza, F.; Giampaoli, S.; Jansen, A.; Menotti, A.; Nedeljkovic, S.; et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 1995, 155, 381–386. [Google Scholar] [CrossRef] [PubMed]
  3. Hertog, M.G. Epidemiological evidence on potential health properties of flavonoids. Proc. Nutr. Soc. 1996, 55, 385–397. [Google Scholar] [CrossRef] [PubMed]
  4. Joshipura, K.J.; Ascherio, A.; Manson, J.E.; Stampfer, M.J.; Rimm, E.B.; Speizer, F.E.; Hennekens, C.H.; Spiegelman, D.; Willett, W.C. Fruit and vegetable intake in relation to risk of ischemic stroke. Jama 1999, 282, 1233–1239. [Google Scholar] [CrossRef]
  5. Kris-Etherton, P.M.; Hecker, K.D.; Bonanome, A.; Coval, S.M.; Binkoski, A.E.; Hilpert, K.F.; Griel, A.E.; Etherton, T.D. Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 2002, 113, 71–88. [Google Scholar] [CrossRef]
  6. Dalgård, C.; Nielsen, F.; Morrow, J.D.; Enghusen-Poulsen, H.; Jonung, T.; Hørder, M.; de Maat, M.P. Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease. Br. J. Nutr. 2009, 101, 263–269. [Google Scholar] [CrossRef]
  7. Sugiura, M.; Ogawa, K.; Yano, M. Effect of chronic administration of fruit extract (Citrus unshiu Marc.) on glucose tolerance in GK rats, a model of type 2 diabetes. Biosci. Biotechnol. Biochem. 2006, 70, 293–295. [Google Scholar] [CrossRef]
  8. Kamata, K.; Kobayashi, T.; Matsumoto, T.; Kanie, N.; Oda, S.; Kaneda, A.; Sugiura, M. Effects of chronic administration of fruit extract (Citrus unshiu Marc) on endothelial dysfunction in streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 2005, 28, 267–270. [Google Scholar] [CrossRef]
  9. La Vecchia, C.; Decarli, A.; Negri, E.; Parazzini, F. Epidemiological aspects of diet and cancer: A summary review of case-control studies from northern Italy. Oncology 1988, 45, 364–370. [Google Scholar] [CrossRef]
  10. Saini, R.K.; Ranjit, A.; Sharma, K.; Prasad, P.; Shang, X.; Gowda, K.G.M.; Keum, Y.S. Bioactive Compounds of Citrus Fruits: A Review of Composition and Health Benefits of Carotenoids, Flavonoids, Limonoids, and Terpenes. Antioxidants 2022, 11, 239. [Google Scholar] [CrossRef]
  11. Liu, S.; Lou, Y.; Li, Y.; Zhang, J.; Li, P.; Yang, B.; Gu, Q. Review of phytochemical and nutritional characteristics and food applications of Citrus L. fruits. Front. Nutr. 2022, 9, 968604. [Google Scholar] [CrossRef]
  12. Barreca, D.; Mandalari, G.; Calderaro, A.; Smeriglio, A.; Trombetta, D.; Felice, M.R.; Gattuso, G. Citrus Flavones: An Update on Sources, Biological Functions, and Health Promoting Properties. Plants 2020, 9, 288. [Google Scholar] [CrossRef]
  13. Tripoli, E.; Guardia, M.L.; Giammanco, S.; Majo, D.D.; Giammanco, M. Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review. Food Chem. 2007, 104, 466–479. [Google Scholar] [CrossRef]
  14. Miceli, N.; Mondello, M.R.; Monforte, M.T.; Sdrafkakis, V.; Dugo, P.; Crupi, M.L.; Taviano, M.F.; De Pasquale, R.; Trovato, A. Hypolipidemic effects of Citrus bergamia Risso et Poiteau juice in rats fed a hypercholesterolemic diet. J. Agric. Food Chem. 2007, 55, 10671–10677. [Google Scholar] [CrossRef] [PubMed]
  15. Ali, M.M.; El Kader, M.A. The influence of naringin on the oxidative state of rats with streptozotocin-induced acute hyperglycaemia. Z. Naturforsch C J. Biosci. 2004, 59, 726–733. [Google Scholar] [CrossRef] [PubMed]
  16. Sugiura, M.; Nakamura, M.; Ikoma, Y.; Yano, M.; Ogawa, K.; Matsumoto, H.; Kato, M.; Ohshima, M.; Nagao, A. Serum carotenoid concentrations are inversely associated with serum aminotransferases in hyperglycemic subjects. Diabetes Res. Clin. Pr. 2006, 71, 82–91. [Google Scholar] [CrossRef]
  17. Vanamala, J.; Leonardi, T.; Patil, B.S.; Taddeo, S.S.; Murphy, M.E.; Pike, L.M.; Chapkin, R.S.; Lupton, J.R.; Turner, N.D. Suppression of colon carcinogenesis by bioactive compounds in grapefruit. Carcinogenesis 2006, 27, 1257–1265. [Google Scholar] [CrossRef]
  18. Murakami, A.; Nakamura, Y.; Ohto, Y.; Yano, M.; Koshiba, T.; Koshimizu, K.; Tokuda, H.; Nishino, H.; Ohigashi, H. Suppressive effects of citrus fruits on free radical generation and nobiletin, an anti-inflammatory polymethoxyflavonoid. BioFactors 2000, 12, 187–192. [Google Scholar] [CrossRef]
  19. Rupasinghe, H.P.; Sekhon-Loodu, S.; Mantso, T.; Panayiotidis, M.I. Phytochemicals in regulating fatty acid β-oxidation: Potential underlying mechanisms and their involvement in obesity and weight loss. Pharmacol. Ther. 2016, 165, 153–163. [Google Scholar] [CrossRef]
  20. Mulvihill, E.E.; Burke, A.C.; Huff, M.W. Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis. Annu. Rev. Nutr. 2016, 36, 275–299. [Google Scholar] [CrossRef]
  21. Russo, C.; Maugeri, A.; Lombardo, G.E.; Musumeci, L.; Barreca, D.; Rapisarda, A.; Cirmi, S.; Navarra, M. The Second Life of Citrus Fruit Waste: A Valuable Source of Bioactive Compounds. Molecules 2021, 26, 5991. [Google Scholar] [CrossRef]
  22. Maqbool, Z.; Khalid, W.; Atiq, H.T.; Koraqi, H.; Javaid, Z.; Alhag, S.K.; Al-Shuraym, L.A.; Bader, D.M.D.; Almarzuq, M.; Afifi, M.; et al. Citrus Waste as Source of Bioactive Compounds: Extraction and Utilization in Health and Food Industry. Molecules 2023, 28, 1636. [Google Scholar] [CrossRef] [PubMed]
  23. Cheng, Y.; Feng, S.; Sheng, C.; Yang, C.; Li, Y. Nobiletin from citrus peel: A promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications. Front. Pharmacol. 2024, 15, 1354809. [Google Scholar] [CrossRef] [PubMed]
  24. Munir, H.; Yaqoob, S.; Awan, K.A.; Imtiaz, A.; Naveed, H.; Ahmad, N.; Naeem, M.; Sultan, W.; Ma, Y. Unveiling the Chemistry of Citrus Peel: Insights into Nutraceutical Potential and Therapeutic Applications. Foods 2024, 13, 1681. [Google Scholar] [CrossRef] [PubMed]
  25. Jung, U.J.; Lee, M.K.; Jeong, K.S.; Choi, M.S. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr. 2004, 134, 2499–2503. [Google Scholar] [CrossRef]
  26. Jeon, S.M.; Bok, S.H.; Jang, M.K.; Lee, M.K.; Nam, K.T.; Park, Y.B.; Rhee, S.J.; Choi, M.S. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci. 2001, 69, 2855–2866. [Google Scholar] [CrossRef]
  27. Choe, S.C.; Kim, H.S.; Jeong, T.S.; Bok, S.H.; Park, Y.B. Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 2001, 38, 947–955. [Google Scholar] [CrossRef]
  28. Li, L.; Bai, S.; Zhao, H.; Tan, J.; Wang, Y.; Zhang, A.; Jiang, L.; Zhao, Y. Dietary Supplementation with Naringin Improves Systemic Metabolic Status and Alleviates Oxidative Stress in Transition Cows via Modulating Adipose Tissue Function: A Lipid Perspective. Antioxidants 2024, 13, 638. [Google Scholar] [CrossRef]
  29. Wang, J.; Wang, Q.; Zhu, S.; Huang, J.; Liu, Z.; Qi, R. Naringin reduces fat deposition by promoting the expression of lipolysis and β-oxidation related genes. Obes. Res. Clin. Pract. 2023, 17, 74–81. [Google Scholar] [CrossRef]
  30. Heo, Y.J.; Lee, M.K.; Im, J.H.; Kim, B.S.; Lee, H.I. Anti-obesity effects of ethanol extract of green Citrus junos peel enriched in naringin and hesperidin in vitro and in vivo. Nutr. Res. Pr. 2025, 19, 1–13. [Google Scholar] [CrossRef]
  31. Li, X.; Yao, Z.; Qi, X.; Cui, J.; Zhou, Y.; Tan, Y.; Huang, X.; Ye, H. Naringin ameliorates obesity via stimulating adipose thermogenesis and browning, and modulating gut microbiota in diet-induced obese mice. Curr. Res. Food Sci. 2024, 8, 100683. [Google Scholar] [CrossRef] [PubMed]
  32. Cha, J.Y.; Cho, Y.S.; Kim, I.; Anno, T.; Rahman, S.M.; Yanagita, T. Effect of hesperetin, a citrus flavonoid, on the liver triacylglycerol content and phosphatidate phosphohydrolase activity in orotic acid-fed rats. Plant Foods Hum. Nutr. 2001, 56, 349–358. [Google Scholar] [CrossRef] [PubMed]
  33. Rapavi, E.; Kocsis, I.; Fehér, E.; Szentmihályi, K.; Lugasi, A.; Székely, E.; Blázovics, A. The effect of citrus flavonoids on the redox state of alimentary-induced fatty liver in rats. Nat. Prod. Res. 2007, 21, 274–281. [Google Scholar] [CrossRef] [PubMed]
  34. Ferreira, P.S.; Spolidorio, L.C.; Manthey, J.A.; Cesar, T.B. Citrus flavanones prevent systemic inflammation and ameliorate oxidative stress in C57BL/6J mice fed high-fat diet. Food Funct. 2016, 7, 2675–2681. [Google Scholar] [CrossRef]
  35. Jia, S.; Hu, Y.; Zhang, W.; Zhao, X.; Chen, Y.; Sun, C.; Li, X.; Chen, K. Hypoglycemic and hypolipidemic effects of neohesperidin derived from Citrus aurantium L. in diabetic KK-A(Y) mice. Food Funct. 2015, 6, 878–886. [Google Scholar] [CrossRef]
  36. Chou, Y.C.; Ho, C.T.; Pan, M.H. Immature Citrus reticulata Extract Promotes Browning of Beige Adipocytes in High-Fat Diet-Induced C57BL/6 Mice. J. Agric. Food Chem. 2018, 66, 9697–9703. [Google Scholar] [CrossRef]
  37. Xu, H.; Yuan, M.; Niu, K.; Yang, W.; Jiang, M.; Zhang, L.; Zhou, J. Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin. Molecules 2024, 29, 976. [Google Scholar] [CrossRef]
  38. Yang, X.; Sun, L.; Feng, D.; Deng, Y.; Liao, W. A lipidomic study: Nobiletin ameliorates hepatic steatosis through regulation of lipid alternation. J. Nutr. Biochem. 2023, 118, 109353. [Google Scholar] [CrossRef]
  39. Koh, Y.C.; Liu, C.P.; Leung, S.Y.; Lin, W.S.; Ho, P.Y.; Ho, C.T.; Pan, M.H. Nobiletin Enhances Skeletal Muscle Mass and Modulates Bile Acid Composition in Diet-Induced Obese Mice. J. Agric. Food Chem. 2025, 73, 9076–9087. [Google Scholar] [CrossRef]
  40. Zhang, M.; Zhang, X.; Zhu, J.; Zhao, D.G.; Ma, Y.Y.; Li, D.; Ho, C.T.; Huang, Q. Bidirectional interaction of nobiletin and gut microbiota in mice fed with a high-fat diet. Food Funct. 2021, 12, 3516–3526. [Google Scholar] [CrossRef]
  41. Elavarasan, J.; Velusamy, P.; Ganesan, T.; Ramakrishnan, S.K.; Rajasekaran, D.; Periandavan, K. Hesperidin-mediated expression of Nrf2 and upregulation of antioxidant status in senescent rat heart. J. Pharm. Pharmacol. 2012, 64, 1472–1482. [Google Scholar] [CrossRef] [PubMed]
  42. Assini, J.M.; Mulvihill, E.E.; Sutherland, B.G.; Telford, D.E.; Sawyez, C.G.; Felder, S.L.; Chhoker, S.; Edwards, J.Y.; Gros, R.; Huff, M.W. Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr−/− mice. J. Lipid Res. 2013, 54, 711–724. [Google Scholar] [CrossRef] [PubMed]
  43. Assini, J.M.; Mulvihill, E.E.; Burke, A.C.; Sutherland, B.G.; Telford, D.E.; Chhoker, S.S.; Sawyez, C.G.; Drangova, M.; Adams, A.C.; Kharitonenkov, A.; et al. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21. Endocrinology 2015, 156, 2087–2102. [Google Scholar] [CrossRef] [PubMed]
  44. Lanza, M.; Scerra, M.; Bognanno, M.; Buccioni, A.; Cilione, C.; Biondi, L.; Priolo, A.; Luciano, G. Fatty acid metabolism in lambs fed citrus pulp. J. Anim. Sci. 2015, 93, 3179–3188. [Google Scholar] [CrossRef]
  45. Lanza, M.; Fasone, V.; Galofaro, V.; Barbagallo, D.; Bella, M.; Pennisi, P. Citrus pulp as an ingredient in ostrich diet: Effects on meat quality. Meat Sci. 2004, 68, 269–275. [Google Scholar] [CrossRef]
  46. Inserra, L.; Priolo, A.; Biondi, L.; Lanza, M.; Bognanno, M.; Gravador, R.; Luciano, G. Dietary citrus pulp reduces lipid oxidation in lamb meat. Meat Sci. 2014, 96, 1489–1493. [Google Scholar] [CrossRef]
  47. Salami, S.A.; O’Grady, M.N.; Luciano, G.; Priolo, A.; McGee, M.; Moloney, A.P.; Kerry, J.P. Quality indices and sensory attributes of beef from steers offered grass silage and a concentrate supplemented with dried citrus pulp. Meat Sci. 2020, 168, 108181. [Google Scholar] [CrossRef]
  48. Tayengwa, T.; Chikwanha, O.C.; Neethling, J.; Dugan, M.E.R.; Mutsvangwa, T.; Mapiye, C. Polyunsaturated fatty acid, volatile and sensory profiles of beef from steers fed citrus pulp or grape pomace. Food Res. Int. 2021, 139, 109923. [Google Scholar] [CrossRef]
  49. Fruet, A.P.B.; Nörnberg, J.L.; Calkins, C.R.; De Mello, A. Effects of different antioxidants on quality of beef patties from steers fed low-moisture distillers grains. Meat Sci. 2019, 154, 119–125. [Google Scholar] [CrossRef]
  50. Bambeni, T.; Tayengwa, T.; Chikwanha, O.C.; Manley, M.; Gouws, P.A.; Marais, J.; Fawole, O.A.; Mapiye, C. Biopreservative efficacy of grape (Vitis vinifera) and clementine mandarin orange (Citrus reticulata) by-product extracts in raw ground beef patties. Meat Sci. 2021, 181, 108609. [Google Scholar] [CrossRef]
  51. Luzardo, S.; Banchero, G.; Ferrari, V.; Ibáñez, F.; Roig, G.; Aznárez, V.; Clariget, J.; La Manna, A. Effect of Fresh Citrus Pulp Supplementation on Animal Performance and Meat Quality of Feedlot Steers. Animals 2021, 11, 3338. [Google Scholar] [CrossRef] [PubMed]
  52. Muroya, S.; Nomura, R.; Nagai, H.; Ojima, K.; Matsukawa, K. Metabolomic profiling of postmortem aged muscle in Japanese Brown beef cattle revealed an interbreed difference from Japanese Black beef. Anim. Biosci. 2023, 36, 506–520. [Google Scholar] [CrossRef] [PubMed]
  53. Muroya, S.; Horiuchi, Y.; Iguchi, K.; Higuchi, T.; Sakamoto, S.; Ojima, K.; Matsukawa, K. Depth of interbreed difference in postmortem bovine muscle determined by CE-FT/MS and LC-FT/MS metabolomics. Metabolites 2024, 14, 261. [Google Scholar] [CrossRef] [PubMed]
  54. Yoshikuni, M.; Iguchi, K.; Otoguro, Y.; Sato, S.; Nagai, H.; Takemura, Y.; Banno, A.; Higuchi, T.; Sakamoto, S.; Muroya, S.; et al. Chiral derivatization LC-TOF/MS analysis reveals presence of D-amino acids in bovine skeletal muscle tissue and the cultured cells. J. Food Compos. Anal. 2025, 144, 107722. [Google Scholar] [CrossRef]
  55. Kuraya, E.; Nakada, S.; Touyama, A.; Itoh, S. Improving the antioxidant functionality of Citrus junos Tanaka (yuzu) fruit juice by underwater shockwave pretreatment. Food Chem. 2017, 216, 123–129. [Google Scholar] [CrossRef]
  56. Yoo, K.M.; Lee, K.W.; Park, J.B.; Lee, H.J.; Hwang, I.K. Variation in major antioxidants and total antioxidant activity of Yuzu (Citrus junos Sieb ex Tanaka) during maturation and between cultivars. J. Agric. Food Chem. 2004, 52, 5907–5913. [Google Scholar] [CrossRef]
  57. National Agriculture and Food Research Organization. Japanese Feeding Standard for Beef Cattle 2008 edn.; Japan Livestock Industry Association: Tokyo, Japan, 2009. (In Japanese) [Google Scholar]
  58. Muroya, S.; Oe, M.; Ojima, K.; Watanabe, A. Metabolomic approach to key metabolites characterizing postmortem aged loin muscle of Japanese Black (Wagyu) cattle. Asian-Australas. J. Anim. Sci. 2019, 32, 1172–1185. [Google Scholar] [CrossRef]
  59. Hargreaves, I.; Heaton, R.A.; Mantle, D. Disorders of Human Coenzyme Q10 Metabolism: An Overview. Int. J. Mol. Sci. 2020, 21, 6695. [Google Scholar] [CrossRef]
  60. Tsujita, T.; Takaku, T. Lipolysis induced by segment wall extract from Satsuma mandarin orange (Citrus unshu Mark). J. Nutr. Sci. Vitaminol. 2007, 53, 547–551. [Google Scholar] [CrossRef]
  61. Nagao, K.; Yamano, N.; Shirouchi, B.; Inoue, N.; Murakami, S.; Sasaki, T.; Yanagita, T. Effects of citrus auraptene (7-geranyloxycoumarin) on hepatic lipid metabolism in vitro and in vivo. J. Agric. Food Chem. 2010, 58, 9028–9032. [Google Scholar] [CrossRef]
  62. Kim, G.S.; Park, H.J.; Woo, J.H.; Kim, M.K.; Koh, P.O.; Min, W.; Ko, Y.G.; Kim, C.H.; Won, C.K.; Cho, J.H. Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells. BMC Complement. Altern. Med. 2012, 12, 31. [Google Scholar] [CrossRef] [PubMed]
  63. John, C.M.; Arockiasamy, S. Enhanced Inhibition of Adipogenesis by Chrysin via Modification in Redox Balance, Lipogenesis, and Transcription Factors in 3T3-L1 Adipocytes in Comparison with Hesperidin. J. Am. Nutr. Assoc. 2022, 41, 758–770. [Google Scholar] [CrossRef] [PubMed]
  64. Lee, H.S.; Heo, C.U.; Song, Y.H.; Lee, K.; Choi, C.I. Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes. Arch. Pharm. Res. 2023, 46, 192–205. [Google Scholar] [CrossRef] [PubMed]
  65. Collins, S. β-Adrenergic Receptors and Adipose Tissue Metabolism: Evolution of an Old Story. Annu. Rev. Physiol. 2022, 84, 1–16. [Google Scholar] [CrossRef]
  66. Kihara-Negishi, F.; Ohkura, N.; Takahashi, Y.; Fujita, T.; Nakamura, Y.; Maruyama, K.; Oshitari, T.; Yamaguchi, S. Nobiletin and 3’-Demethyl Nobiletin Activate Brown Adipocytes upon β-Adrenergic Stimulation. Biol. Pharm. Bull. 2022, 45, 528–533. [Google Scholar] [CrossRef]
  67. Guo, L.X.; Chen, G.; Yin, Z.Y.; Zhang, Y.H.; Zheng, X.X. p-Synephrine exhibits anti-adipogenic activity by activating the Akt/GSK3β signaling pathway in 3T3-L1 adipocytes. J. Food Biochem. 2019, 43, e13033. [Google Scholar] [CrossRef]
  68. Ueda, S.; Hosoda, M.; Kasamatsu, K.; Horiuchi, M.; Nakabayashi, R.; Kang, B.; Shinohara, M.; Nakanishi, H.; Ohto-Nakanishi, T.; Yamanoue, M.; et al. Production of Hydroxy Fatty Acids, Precursors of γ-Hexalactone, Contributes to the Characteristic Sweet Aroma of Beef. Metabolites 2022, 12, 332. [Google Scholar] [CrossRef]
  69. Inagaki, S.; Amano, Y.; Kumazawa, K. Identification and Characterization of Volatile Components Causing the Characteristic Flavor of Wagyu Beef (Japanese Black Cattle). J. Agric. Food Chem. 2017, 65, 8691–8695. [Google Scholar] [CrossRef]
  70. Yoshinaga, K.; Tago, A.; Yoshinaga-Kiriake, A.; Gotoh, N. Characterization of lactones in Wagyu (Japanese beef) and imported beef by combining solvent extraction and gas chromatography–mass spectrometry. LWT 2021, 135, 110015. [Google Scholar] [CrossRef]
  71. Vangaveti, V.N.; Jansen, H.; Kennedy, R.L.; Malabu, U.H. Hydroxyoctadecadienoic acids: Oxidised derivatives of linoleic acid and their role in inflammation associated with metabolic syndrome and cancer. Eur. J. Pharmacol. 2016, 785, 70–76. [Google Scholar] [CrossRef]
  72. Harmon, G.S.; Lam, M.T.; Glass, C.K. PPARs and lipid ligands in inflammation and metabolism. Chem. Rev. 2011, 111, 6321–6340. [Google Scholar] [CrossRef] [PubMed]
  73. Nagy, L.; Tontonoz, P.; Alvarez, J.G.; Chen, H.; Evans, R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93, 229–240. [Google Scholar] [CrossRef] [PubMed]
  74. Wang, L.; Gill, R.; Pedersen, T.L.; Higgins, L.J.; Newman, J.W.; Rutledge, J.C. Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J. Lipid Res. 2009, 50, 204–213. [Google Scholar] [CrossRef]
  75. Niki, E. Lipid peroxidation: Physiological levels and dual biological effects. Free Radic. Biol. Med. 2009, 47, 469–484. [Google Scholar] [CrossRef] [PubMed]
  76. Myant, N.B.; Mitropoulos, K.A. Cholesterol 7 alpha-hydroxylase. J. Lipid Res. 1977, 18, 135–153. [Google Scholar] [CrossRef] [PubMed]
  77. Folcik, V.A.; Cathcart, M.K. Predominance of esterified hydroperoxy-linoleic acid in human monocyte-oxidized LDL. J. Lipid Res. 1994, 35, 1570–1582. [Google Scholar] [CrossRef]
  78. Jia, S.J.; Jiang, D.J.; Hu, C.P.; Zhang, X.H.; Deng, H.W.; Li, Y.J. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Vasc. Pharmacol. 2006, 44, 143–148. [Google Scholar] [CrossRef]
  79. Jiang, J.L.; Zhang, X.H.; Li, N.S.; Rang, W.Q.; Feng, Y.; Hu, C.P.; Li, Y.J.; Deng, H.W. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity. Cardiovasc. Drugs Ther. 2006, 20, 281–294. [Google Scholar] [CrossRef]
  80. Lee, Y.H.; Kim, S.N.; Kwon, H.J.; Maddipati, K.R.; Granneman, J.G. Adipogenic role of alternatively activated macrophages in β-adrenergic remodeling of white adipose tissue. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2016, 310, R55–R65. [Google Scholar] [CrossRef]
  81. Coelho, R.C.; Hermsdorff, H.H.; Bressan, J. Anti-inflammatory properties of orange juice: Possible favorable molecular and metabolic effects. Plant Foods Hum. Nutr. 2013, 68, 1–10. [Google Scholar] [CrossRef]
  82. Tejada, S.; Pinya, S.; Martorell, M.; Capó, X.; Tur, J.A.; Pons, A.; Sureda, A. Potential Anti-inflammatory Effects of Hesperidin from the Genus Citrus. Curr. Med. Chem. 2018, 25, 4929–4945. [Google Scholar] [CrossRef] [PubMed]
  83. Ryan, R.O. Metabolic annotation of 2-ethylhydracrylic acid. Clin. Chim. Acta 2015, 448, 91–97. [Google Scholar] [CrossRef] [PubMed]
  84. Thorpe, C.; Kim, J.-J.P. Structure and mechanism of action of the Acyl-CoA dehydrogenases. FASEB J. 1995, 9, 718–725. [Google Scholar] [CrossRef] [PubMed]
  85. Henriques, B.J.; Katrine Jentoft Olsen, R.; Gomes, C.M.; Bross, P. Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease. Gene 2021, 776, 145407. [Google Scholar] [CrossRef]
  86. Lee, S.K.; Lee, J.O.; Kim, J.H.; Kim, N.; You, G.Y.; Moon, J.W.; Sha, J.; Kim, S.J.; Lee, Y.W.; Kang, H.J.; et al. Coenzyme Q10 increases the fatty acid oxidation through AMPK-mediated PPARα induction in 3T3-L1 preadipocytes. Cell. Signal. 2012, 24, 2329–2336. [Google Scholar] [CrossRef]
  87. Bailly, C. Insights into the Bioactivities and Mechanism of Action of the Microbial Diketopiperazine Cyclic Dipeptide Cyclo(L-leucyl-L-prolyl). Mar. Drugs 2025, 23, 397. [Google Scholar] [CrossRef]
  88. Zhang, X.; Zhang, Y.; Gao, W.; Guo, Z.; Wang, K.; Liu, S.; Duan, Z.; Chen, Y. Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms. Life Sci. 2021, 277, 119487. [Google Scholar] [CrossRef]
  89. Toyoda, A.; Sato, M.; Muto, M.; Goto, T.; Miyaguchi, Y.; Inoue, E. Metabolomic analyses of plasma and liver of mice fed with immature Citrus tumida peel. Biosci. Biotechnol. Biochem. 2020, 84, 1098–1104. [Google Scholar] [CrossRef]
  90. Sugiura, M.; Ohshima, M.; Ogawa, K.; Yano, M. Chronic administration of Satsuma mandarin fruit (Citrus unshiu Marc.) improves oxidative stress in streptozotocin-induced diabetic rat liver. Biol. Pharm. Bull. 2006, 29, 588–591. [Google Scholar] [CrossRef]
Metabolites 16 00201 g001
Figure 1. Heatmap result of HCA (A) and volcano plot (B) of metabolite profile data from CE-TOF/MS and LC-TOF/MS metabolomics profiles of JBR beef with and without DYS. In the HCA, the results of statistically representative top 50 metabolites were used. Subject means individual animal. The beef samples with and without DYS are grouped with green and red bars, respectively.
Figure 1. Heatmap result of HCA (A) and volcano plot (B) of metabolite profile data from CE-TOF/MS and LC-TOF/MS metabolomics profiles of JBR beef with and without DYS. In the HCA, the results of statistically representative top 50 metabolites were used. Subject means individual animal. The beef samples with and without DYS are grouped with green and red bars, respectively.
Metabolites 16 00201 g001
Metabolites 16 00201 g002
Figure 2. MSEA results for metabolomic difference in aged beef with and without DYS. Enrichment ratio is computed by (observed hits)/(expected hits).
Figure 2. MSEA results for metabolomic difference in aged beef with and without DYS. Enrichment ratio is computed by (observed hits)/(expected hits).
Metabolites 16 00201 g002
Metabolites 16 00201 g003
Figure 3. Heatmap result of HCA (A) and volcano plot (B) of metabolite profile data from CE-TOF/MS metabolomics profiles of JBR fresh liver with and without DYS. In the HCA, the results of statistically representative top 50 metabolites were used. Subject means individual animal. The beef samples with and without DYS are grouped with green and red bars, respectively.
Figure 3. Heatmap result of HCA (A) and volcano plot (B) of metabolite profile data from CE-TOF/MS metabolomics profiles of JBR fresh liver with and without DYS. In the HCA, the results of statistically representative top 50 metabolites were used. Subject means individual animal. The beef samples with and without DYS are grouped with green and red bars, respectively.
Metabolites 16 00201 g003
Metabolites 16 00201 g004
Figure 4. MSEA results for metabolomic difference in fresh liver with and without DYS. Enrichment ratio is computed by (observed hits)/(expected hits).
Figure 4. MSEA results for metabolomic difference in fresh liver with and without DYS. Enrichment ratio is computed by (observed hits)/(expected hits).
Metabolites 16 00201 g004
Metabolites 16 00201 g005
Figure 5. Hypothetic scheme that shows representative muscle metabolites (red) and microenvironment metabolisms affected by DYS in this study. Isoleucine catabolism is tightly linked not only with β-oxidation and FAD redox reaction in ETC but also with 2-EHAA generation. α-KG: α-ketoglutarate; FTF:UO: electron transfer flavoprotein-ubiquinone oxidoreductase.
Figure 5. Hypothetic scheme that shows representative muscle metabolites (red) and microenvironment metabolisms affected by DYS in this study. Isoleucine catabolism is tightly linked not only with β-oxidation and FAD redox reaction in ETC but also with 2-EHAA generation. α-KG: α-ketoglutarate; FTF:UO: electron transfer flavoprotein-ubiquinone oxidoreductase.
Metabolites 16 00201 g005
Table 1. Beef quality traits of JBR steers finished with/without dietary yuzu supplementation (DYS).
Table 1. Beef quality traits of JBR steers finished with/without dietary yuzu supplementation (DYS).
None DYS
Quality Traits Mean/ScoreS.D.Mean/ScoreS.D.p-Value
Finishing and carcass resultsMean Mean
Daily gain (kg/d)0.570.130.580.230.947
Final body weight (kg)699.3318.55724.3340.940.476
Carcass weight (kg)433.337.39469.2713.400.191
Rib eye area (cm2)46.675.7950.335.250.543
Subcutaneous fat thickness (cm)2.931.282.070.330.407
Grading scoreScore Score
Beef marbling (1–12)3, 4, 3-2, 3, 3-0.302
Beef color (1–5)5, 4, 5-5, 5, 5-0.700
Beef fat (1–5)3, 2, 2-4, 4, 4-0.050
S.D.: standard deviation.
Table 2. Differently altered metabolites by dietary yuzu supplementation (DYS) in beef (p < 0.100).
Table 2. Differently altered metabolites by dietary yuzu supplementation (DYS) in beef (p < 0.100).
MetaboliteFold Change (DYS/None)p-Value
2-Ethylhydracrylic acid0.18<0.001
γ-Tocopherol0.520.002
Coenzyme Q100.530.002
Sphingomyelin(d18:1/16:0)0.150.003
9(S)-hydroxyoctadecadienoic acid1.590.004
Cyclo(-Leu-Pro)8.720.016
Spermidine1.270.026
Cys-Gly0.340.030
Tyr-Arg0.120.032
Palmitoylcarnitine0.510.036
Asymmetric dimethylarginine1.550.039
7α-Hydroxycholesterol1.690.049
Histamine1.390.051
Pyrraline2.830.057
Oxidized glutatihone (GSSG)1.450.059
Nω-Methylarginine2.090.063
Isoglutamic acid0.470.064
Cortisol0.540.064
Ethanolamine phosphate1.300.073
Acylcarnitine(14:0)0.420.080
Glycine1.220.083
Linoleyl ethanolamide1.440.088
Acylcarnitine(18:1)0.480.092
Table 3. Differently altered metabolites by dietary yuzu supplementation (DYS) in liver (p < 0.100).
Table 3. Differently altered metabolites by dietary yuzu supplementation (DYS) in liver (p < 0.100).
MetaboliteFold Change (DYS/None)p-Value
Acetyl-CoA1.870.002
6-Phosphogluconic acid2.500.003
Thiamine0.610.006
S-Methylglutathione1.550.010
ATP3.550.013
Ribulose 5-phosphate2.510.026
ADP1.980.031
Ala-Ala0.690.033
Riboflavin0.610.042
Ascorbate 2-sulfate0.630.044
Succinic acid0.600.047
Pantothenic acid0.540.054
Glutamic acid0.770.059
GDP2.880.060
ADP-ribose1.870.060
4-Oxopyrrolidine-2-carboxylic acid0.800.066
Putrescine0.550.067
CMP-N-acetylneuraminate3.130.067
5-Hydroxylysine0.800.080
Glucose 1-phosphate1.860.085
Sarcosine1.440.086
Glucose 6-phosphate1.870.089
Citric acid1.450.091
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Muroya, S.; Ojima, K.; Banno, A.; Nagai, H.; Kakibuchi, K.; Higuchi, T.; Sakamoto, S.; Matsukawa, K. Dietary Citrus Peel Supplementation Enhances Hepatic Energy Metabolism, Muscle 9-HODE Generation and Isoleucine Catabolism in Beef Cattle. Metabolites 2026, 16, 201. https://doi.org/10.3390/metabo16030201

AMA Style

Muroya S, Ojima K, Banno A, Nagai H, Kakibuchi K, Higuchi T, Sakamoto S, Matsukawa K. Dietary Citrus Peel Supplementation Enhances Hepatic Energy Metabolism, Muscle 9-HODE Generation and Isoleucine Catabolism in Beef Cattle. Metabolites. 2026; 16(3):201. https://doi.org/10.3390/metabo16030201

Chicago/Turabian Style

Muroya, Susumu, Koichi Ojima, Arata Banno, Hirotaka Nagai, Kazumasa Kakibuchi, Takuma Higuchi, Shuji Sakamoto, and Kazutsugu Matsukawa. 2026. "Dietary Citrus Peel Supplementation Enhances Hepatic Energy Metabolism, Muscle 9-HODE Generation and Isoleucine Catabolism in Beef Cattle" Metabolites 16, no. 3: 201. https://doi.org/10.3390/metabo16030201

APA Style

Muroya, S., Ojima, K., Banno, A., Nagai, H., Kakibuchi, K., Higuchi, T., Sakamoto, S., & Matsukawa, K. (2026). Dietary Citrus Peel Supplementation Enhances Hepatic Energy Metabolism, Muscle 9-HODE Generation and Isoleucine Catabolism in Beef Cattle. Metabolites, 16(3), 201. https://doi.org/10.3390/metabo16030201

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop